Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...
New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with 80% facing critical healthcare barriers.